-
-
-
-
-
๐๐ฒ๐ญ๐ก๐ฌ, ๐๐ข๐๐ฌ ๐๐ง๐ ๐๐จ๐ฐ๐ง๐ซ๐ข๐ ๐ก๐ญ ๐๐ญ๐ฎ๐ฉ๐ข๐๐ข๐ญ๐ฒ: ๐๐๐ญ ๐๐ฎ๐ญ ๐ญ๐ก๐ ๐๐ก๐จ๐ฏ๐๐ฅ - ๐๐ก๐ฒ ๐๐ฏ๐๐ซ๐ฒ๐ญ๐ก๐ข๐ง๐ ๐๐จ๐ฎ ๐๐ง๐จ๐ฐ ๐ข๐ฌ ๐๐ซ๐จ๐ง๐
120.000VND120.000VND× -
๐๐ก๐ ๐๐๐ฏ๐๐ง๐ฌ๐๐๐ซ ๐๐ฒ๐ง๐๐ฌ๐ญ๐ฒ
180.000VND180.000VND× -
-
-
-
-
-
-
-
๐๐จ๐ฐ ๐๐๐ง๐ฒ ๐๐ข๐ ๐ก๐ญ๐๐ฎ๐ฅ๐๐ฌ ๐๐จ๐๐ฌ ๐๐ญ ๐๐๐ค๐ ๐๐จ ๐๐ก๐๐ง๐ ๐ ๐ ๐๐ฅ๐๐ง๐๐ญ?: ๐๐ ๐๐๐ฒ๐ฌ ๐ญ๐จ ๐๐๐ฏ๐ ๐๐ฅ๐๐ง๐๐ญ ๐๐๐ซ๐ญ๐ก
120.000VND120.000VND× -
-
-
-
-
-
-
-
-
-
๐๐ฒ๐๐ฅ๐จ๐ข๐ ๐๐๐ฅ๐ฅ๐ฌ
Author: Spencer A. Douglas, 154 pages, hardcover.
In this book the authors present current research in the study of the biology and regulation, role in cancer progression and potential implications for therapy of myeloid cells. Topics discussed include the differentiation signalling induced by retinoic acid and vitamin D3; proline rich homeodomain (Prh/Hhex) protein in the control of haematopoiesis and myeloid cell proliferation and its potential as a therapeutic target in myeloid leukaemias and other cancers; apoptosis, cell cycle and epigenetic processes deregulation in myeloproliferative neoplasms; use of animal models to evaluate myeloid cell dysfunction in cancer; use of animal models to evaluate myeloid cell dysfunction in cancer; and the biology of myeloid cells mediating tumour recurrence after radiotherapy.
99.000VND









